Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid
Overview
Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: January 2018
Interventions
- Procedure: Thyroidecomt and lymphectomy
- Patients underwent total thyroidectomy or lobectomy associated to lymph node sampling or neck lymphectomy
Arms, Groups and Cohorts
- PTMC
- Patients with papillary microcarcinoma of the thyroid
Clinical Trial Outcome Measures
Primary Measures
- Incidence of lymph node metastasis
- Time Frame: 1 year
- To define the incidence of lymph node metastasis in patients with papillary microcarcinoma
Secondary Measures
- Predicrive factors of lymph node metastasis
- Time Frame: 1 year
- To assesss predictive factors of lymph node metastasis
Participating in This Clinical Trial
Inclusion Criteria
Patients with papillary microcarcinoma of the thyroid Exclusion Criteria:
Patients with thyroid nodules > 1 cm; incomplete data
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of Cagliari
- Provider of Information About this Clinical Study
- Principal Investigator: Fabio Medas, Assistant Professor – University of Cagliari
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.